AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2022
Apr 19, 2022
30870_dirs_2022-04-18_99aa57b2-3890-4528-9c2d-6c7dda409a1a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2022-04-08
Reporting Person: Harrington Robert Arthur (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-04-08 | Non-Qualified Stock Option (right to buy) | $41.69 | A | 35000 | Acquired | 2032-04-08 | Common Stock (35000) | Direct |
Footnotes
F1: Options shall vest and become exercisable in 36 equal monthly installments as from the date of the grant.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18